相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antibody-Mediated Immunity against Tuberculosis: Implications for Vaccine Development
Jacqueline M. Achkar et al.
CELL HOST & MICROBE (2013)
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
Michele D. Tameris et al.
LANCET (2013)
Nonclinical Development of BCG Replacement Vaccine Candidates
Kamalakannan Velmurugan et al.
VACCINES (2013)
Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010
Matteo Zignol et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2012)
Comparison of interferon-γ-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection
J. Cowan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Totally Drug-Resistant Tuberculosis in India
Zarir F. Udwadia et al.
CLINICAL INFECTIOUS DISEASES (2012)
A Human Challenge Model for Mycobacterium tuberculosis Using Mycobacterium bovis Bacille Calmette-Guerin
Angela M. Minassian et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Correlation of Mycobacterium Tuberculosis Specific and Non-Specific Quantitative Th1 T-Cell Responses with Bacillary Load in a High Burden Setting
Grant Theron et al.
PLOS ONE (2012)
Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
Tom H. M. Ottenhoff et al.
PLOS PATHOGENS (2012)
Tuberculosis and HIV Co-Infection
Andrzej Pawlowski et al.
PLOS PATHOGENS (2012)
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
D. Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Membrane-Bound IL-22 after De Novo Production in Tuberculosis and Anti-Mycobacterium tuberculosis Effector Function of IL-22+ CD4+ T Cells
Gucheng Zeng et al.
JOURNAL OF IMMUNOLOGY (2011)
Preclinical Development of an In Vivo BCG Challenge Model for Testing Candidate TB Vaccine Efficacy
Angela M. Minassian et al.
PLOS ONE (2011)
Aerosol vaccines for tuberculosis: A fine line between protection and pathology
David A. Hokey et al.
TUBERCULOSIS (2011)
The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices
Alice Zwerling et al.
PLOS MEDICINE (2011)
Experimental human challenge infections can accelerate clinical malaria vaccine development
Robert W. Sauerwein et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Extensively drug-resistant tuberculosis treatment outcome in Iran: a case series of seven patients
Mohammad R. Masjedi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
New vaccines for tuberculosis
Stefan H. E. Kaufmann et al.
LANCET (2010)
Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli Super Extensively Drug-Resistant Tuberculosis or Totally Drug-Resistant Strains in Iran
Ali Akbar Velayati et al.
CHEST (2009)
Tuberculosis vaccine research: the impact of immunology
Lewellys F. Barker et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
How B cells shape the immune response against Mycobacterium tuberculosis
Paul J. Maglione et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level
A. A. Velayati et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens
Meredith M. Curtis et al.
IMMUNOLOGY (2009)
Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model
Philana Ling Lin et al.
INFECTION AND IMMUNITY (2009)
Whole genome sequence analysis of Mycobacterium bovis bacillus Calmette-Guerin (BCG) Tokyo 172: A comparative study of BCG vaccine substrains
Masaaki Seki et al.
VACCINE (2009)
Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis
Ronggai Sun et al.
VACCINE (2009)
A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis
Crystal Y. Chen et al.
PLOS PATHOGENS (2009)
Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans
Lyudmila Lyakh et al.
IMMUNOLOGICAL REVIEWS (2008)
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa
Tony Hawkridge et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Tuberculosis in Africa - Combating an HIV-driven crisis.
Richard E. Chaisson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
AIDS-Related Tuberculosis in Rio de Janeiro, Brazil
Antonio G. Pacheco et al.
PLOS ONE (2008)
Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques
Lauren A. Hirao et al.
VACCINE (2008)
Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid
Jean D. Boyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Dose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates
Virginia Davids et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Effect of BCG vaccination on childhood tuberculous meningitis and miliarytuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness
BB Trunz et al.
LANCET (2006)
The success and failure of BCG - implications for a novel tuberculosis vaccine
P Andersen et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs
A Williams et al.
INFECTION AND IMMUNITY (2005)
PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis
D Elias et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2005)
Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?
GAW Rook et al.
VACCINE (2005)
IL-4 in tuberculosis: implications for vaccine design
GAW Rook et al.
TRENDS IN IMMUNOLOGY (2004)
Pulmonary tuberculosis in BALB/c mice with nonfunctional IL-4 genes: changes in the inflammatory effects of TNF-alpha and in the regulation of fibrosis
R Hernandez-Pando et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
H McShane et al.
NATURE MEDICINE (2004)
Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection
JM Tufariello et al.
LANCET INFECTIOUS DISEASES (2003)
Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara
NP Goonetilleke et al.
JOURNAL OF IMMUNOLOGY (2003)
Failure of the Mycobacterium bovis BCG vaccine:: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis
L Brandt et al.
INFECTION AND IMMUNITY (2002)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi
GF Black et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease
A Wangoo et al.
JOURNAL OF IMMUNOLOGY (2001)
Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway
DA Lammas et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
分享论文
